(Q51888776)

English

Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.

scientific article published on 8 April 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

1 reference

based on heuristic

inferred from title

immunohistochemistry

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Matthias Preusser

1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

12

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Guido Reifenberger

4

object named as

Guido Reifenberger

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

3

object named as

Jörg Felsberg

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

author name string

Robert Charles Janzer

2

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Marie-France Hamou

5

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Annie-Claire Diserens

6

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Roger Stupp

7

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Thierry Gorlia

8

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Christine Marosi

9

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Harald Heinzl

10

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Johannes A Hainfellner

11

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

publication date

8 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Brain Pathology

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

18

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

4

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

520-532

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase π in glioblastoma and the survival of the patients treated with nimustine hydrochloride: An immunohistochemical analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Oligodendrogliomas lacking O6-methylguanine-DNA-methyltransferase expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Inducibility of the DNA repair gene encoding O6-methylguanine-DNA methyltransferase in mammalian cells by DNA-damaging treatments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Induction of the alkyltransferase (MGMT) gene by DNA damaging agents and the glucocorticoid dexamethasone and comparison with the response of base excision repair genes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Tissue microarrays for high-throughput molecular profiling of tumor specimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Variability and regulation of O6-alkylguanine-DNA alkyltransferase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2008.00153.X

21 January 2018

Identifiers

10.1111/J.1750-3639.2008.00153.X

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/18400046

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51888776&oldid=1698528434"